Lyell Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Lyell Wealth Management's IDXX Position: Q3 2026 in Review
Lyell Wealth Management reduced its Idexx Laboratories (IDXX) stake by 2.8% in Q3 2026, selling an estimated $346K and leaving 22,028 shares worth $11.5M. The position accounts for 0.68% of the portfolio, ranked #44.
Lyell Wealth Management first reported a position in IDXX in Q2 2019 and has held it in 30 quarters since. The position peaked at $15.8M in Q4 2025. 1,261 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.
- Lyell Wealth Management held 22,028 shares of Idexx Laboratories worth $11.5M as of Q3 2026.
- Lyell Wealth Management sold 632 Idexx Laboratories shares in Q3 2026, an estimated $346K.
- Idexx Laboratories made up 0.68% of Lyell Wealth Management's portfolio in Q3 2026, its #44 holding.
- Lyell Wealth Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 30 quarters since.
- Lyell Wealth Management's Idexx Laboratories position peaked at $15.8M in Q4 2025.
- 1,261 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.
Based on Lyell Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.